2018
DOI: 10.1001/jamaneurol.2018.0805
|View full text |Cite
|
Sign up to set email alerts
|

Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis

Abstract: A 2014 study 1 reported that autoimmune aquaporin 4 (AQP4) channelopathy was the most common cause of immunemediated recurrent longitudinally extensive transverse myelitis (rLETM), with seropositivity in 42 of 47 cases (89%). Autoimmune myelin oligodendrocyte glycoproteinopathy (MOG-opathy) with serum antibodies targeting MOG (MOG-IgG

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 6 publications
0
10
0
Order By: Relevance
“…Both AQP4-IgG-seropositive NMOSD and MOG-IgG-seropositive encephalomyelitis follow a mostly relapsing-remitting disease course and - as humorally mediated autoimmune diseases - should be distinguished from MS in terms of pathogenesis, prognosis, and therapy. Rarely, antibodies targeting the astrocytic structural protein glial fibrillary astrocyte protein (GFAP) can be detected in the CSF of some patients presenting with symptoms of meningoencephalomyelitis [ 49 , 92 ].…”
Section: Non-infectious Inflammatory Diseasesmentioning
confidence: 99%
“…Both AQP4-IgG-seropositive NMOSD and MOG-IgG-seropositive encephalomyelitis follow a mostly relapsing-remitting disease course and - as humorally mediated autoimmune diseases - should be distinguished from MS in terms of pathogenesis, prognosis, and therapy. Rarely, antibodies targeting the astrocytic structural protein glial fibrillary astrocyte protein (GFAP) can be detected in the CSF of some patients presenting with symptoms of meningoencephalomyelitis [ 49 , 92 ].…”
Section: Non-infectious Inflammatory Diseasesmentioning
confidence: 99%
“…In a cohort study on 276 subjects with MOGAD, the presence of myelitis at onset, alone or in combination with other presentations, was associated with decreased risk of relapse compared to other non-myelitis phenotypes (HR, 0.41; 95% CI, 0.20–0.88; P = 0.01) ( 114 ). The most common phenotype of MOGAD relapses is ON, regardless of the initial clinical presentation, and recurrent episodes of myelitis as the sole clinical phenotype of MOGAD are uncommon ( 115 , 116 ). Although evidence is still limited, a relapse-independent disease progression is considered extremely rare in MOGAD, and a gradually progressive disease course should prompt careful consideration of alternative diagnoses ( 117 ).…”
Section: Discussionmentioning
confidence: 99%
“…Often a watchful waiting approach is pursued at initial presentation as a monophasic course is commonly encountered. [12][13][14][15] Applicable Guidelines and Areas of Uncertainty…”
Section: Prognosismentioning
confidence: 99%